Christopher R. Barker - 30 Mar 2022 Form 4 Insider Report for SELECTIS HEALTH, INC. (GBCS)

Reporting relationship: PRESIDENT AND COO, Director
Issuer ticker: GBCS
Reported as of: 30 Mar 2022
Net transaction value: +$700,000
SEC form: 4
Accepted by SEC: 07 Apr 2022, 12:50:19 UTC
Prior SEC filing: 13 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Christopher R. Barker

Key filing fact

Christopher R. Barker filed Form 4 for SELECTIS HEALTH, INC. (GBCS) on 07 Apr 2022.

Key facts

This page summarizes Christopher R. Barker's Form 4 filing for SELECTIS HEALTH, INC. (GBCS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2022, 12:50.

Change

Previous filing in this sequence was filed on 13 Jul 2021.
Current net transaction value: +$700,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GBCS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 80,134
Date: 30 Mar 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GBCS transaction Derivative

Common Stock Options

Award

Transaction value: $700,000
Shares: +100,000
Change %
Price: $7.00
Shares after: 100,000
Date: 30 Mar 2022
Ownership: Direct
Underlying class: Common stock
Underlying amount: 100,000
Exercise price: $7.00

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Total number of shares gives effect to 2021 1 for 10 reverse stock split.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .